Fundraising FoxSword Bio
2 known investors
Find your way into Sword Bio
Sign up to see every warm intro you have to Sword Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sword Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
Founders & leadership
DD
Dave DingottCEO and FounderDave Dingott is CEO and founder of Sword Bio, a bioanalytical contract research organization providing assay development and testing services for pharmaceutical companies. He previously founded Corente, which was sold to Oracle, and served on the board of Cearna, Inc. through its acquisition by Allergan/Abbvie.
Investors · 2
Angel Physicians Fundlisted by Angel Physicians Fund
How we know: Angel Physicians Fund's portfolio page · Not right? Tell us
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Sword Bio do?
- Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
- Who are Sword Bio's investors?
- Sword Bio's investors include Angel Physicians Fund, Elevate Ventures.